Monday, 17 June 2019
Latest news
Main » Endo International PLC's (ENDP) Hold Rating Setd at Oppenheimer Stake, Inc

Endo International PLC's (ENDP) Hold Rating Setd at Oppenheimer Stake, Inc

16 April 2018

The Hotchkis & Wiley Capital Management Llc holds 14.01 million shares with $435.07M value, down from 14.33M last quarter. Endo Intl Plc now has $1.22 billion valuation. The stock decreased 1.82% or $1.59 during the last trading session, reaching $85.54. About 2.03 million shares traded. Movado Group, Inc. (NYSE:MOV) has risen 36.40% since April 15, 2017 and is uptrending. It has underperformed by 11.55% the S&P500.

Investors sentiment increased to 1.13 in 2017 Q4. It's up 0.01, from 1.12 in 2017Q3. Endo International had a negative net margin of 58.68% and a positive return on equity of 81.03%. Gabelli Funds Limited Liability Corp owns 237,000 shares. 73 funds opened positions while 207 raised stakes. Sold All: 37 Reduced: 61 Increased: 72 New Position: 39.

Analysts forecast that Endo International plc (NASDAQ:ENDP) (TSE:ENL) will report earnings per share of $0.54 for the current fiscal quarter, according to Zacks. During the same quarter previous year, the business posted $1.36 EPS. The company reported $0.77 EPS for the quarter, beating the consensus estimate of $0.62 by $0.15.

Broadfin Capital Llc holds 3.09% of its portfolio in Endo International plc for 2.44 million shares. Alps Advisors Inc. now owns 307,839 shares of the company's stock worth $2,386,000 after acquiring an additional 57,328 shares in the last quarter. Proshare Limited Liability Company holds 0.01% or 143,562 shares in its portfolio. The New York-based Deltec Asset Management Llc has invested 1.22% in the stock. Bogle Mgmt Limited Partnership De stated it has 1.97 million shares or 1.12% of all its holdings.

Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The company has a market capitalization of $1,255.17, a P/E ratio of 1.43 and a beta of 0.38. Generic Pharmaceuticals segment provides tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics, and transdermal patches for pain management, urology, central nervous system disorders, immunosuppression, oncology, womenÂ's health, and cardiovascular disease markets. Needham maintained it with "Buy" rating and $10000 target in Monday, June 12 report. ENDP was included in 4 notes of analysts from November 9, 2016. State Of Wisconsin Board holds 0% of its portfolio in Endo International plc (NASDAQ:ENDP) for 45,360 shares. Rafferty Asset Management Limited Liability has invested 0.05% in Endo International plc (NASDAQ:ENDP). The stock has an average rating of "Hold" and a consensus price target of $24.76. The rating was downgraded by Citigroup to "Neutral" on Thursday, January 5.

Shares of Endo International stock traded down $0.14 during trading on Friday, reaching $5.48. Based on an average daily volume of 5,015,686 shares, the days-to-cover ratio is now 7.2 days.

Endo International PLC (NASDAQ:ENDP) last released its earnings results on Tuesday, February 28th. It has underperformed by 56.41% the S&P500.

Among 5 analysts covering Puretech Health Plc (LON:PRTC), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 96% are positive. Four equities research analysts have rated the stock with a sell rating, sixteen have assigned a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. On Friday, November 13 the stock rating was upgraded by Standpoint Research to "Buy". The firm has "Buy" rating by Peel Hunt given on Tuesday, December 19. The rating was maintained by Liberum Capital with "Buy" on Wednesday, May 10. Cantor Fitzgerald set a $7.00 price objective on shares of Endo International and gave the stock a "hold" rating in a report on Thursday, January 11th. The rating was maintained by Canaccord Genuity on Monday, February 8 with "Buy". BMO Capital Markets maintained it with "Market Perform" rating and $10 target in Monday, November 13 report. Mizuho maintained Microchip Technology Incorporated (NASDAQ:MCHP) on Wednesday, February 8 with "Neutral" rating. On Wednesday, December 7 the stock rating was downgraded by Credit Suisse to "Underperform".

Investors sentiment increased to 1.21 in Q4 2017. Its up 0.01, from 1.12 in 2017Q3. It increased, as 47 investors sold MUR shares while 92 reduced holdings.

Hedge funds have recently added to or reduced their stakes in the business. Shelton Capital holds 0.01% or 15,857 shares. Macquarie Group invested 0% of its portfolio in Endo International plc (NASDAQ:ENDP). The stock of Endo International plc (NASDAQ:ENDP) has "Outperform" rating given on Thursday, September 29 by Northland Capital. Nuwave Mngmt Limited accumulated 4,014 shares or 0.15% of the stock. Tiaa Cref Invest Mngmt Lc reported 382,801 shares. 31,470 are owned by Fruth Mgmt. Nuveen Asset Ltd Liability Corp accumulated 162,901 shares. Tctc Holdg Lc owns 40,294 shares.

Globeflex Capital LP increased Raymond James Financial Inc (RJF) stake by 34680% reported in 2017Q4 SEC filing. Mitsubishi UFJ Trust & Banking Corp now owns 425,759 shares of the company's stock valued at $8,579,000 after buying an additional 4,544 shares during the last quarter. Blackrock stated it has 21.42 million shares or 0.01% of all its holdings.

Financial & Investment Management Group Ltd decreased Cott Corp Que (NYSE:COT) stake by 141,922 shares to 214,401 valued at $3.57 million in 2017Q4. Hexavest holds 1.13 million shares or 0.1% of its portfolio.

Since January 9, 2018, it had 0 buys, and 17 selling transactions for $7.24 million activity.